Strides Pharma Science Limited — Others, 07-08-2025: Shareholders meeting

Strides Pharma Science Limited conducted its 34th Annual General Meeting via video conference, where shareholders received a performance update for the financial year ended March 31, 2025, from management. Key decisions included the adoption of the audited financial statements for FY25, notably without any qualifications from auditors, and the declaration of a final dividend. Shareholders also approved the re-appointment of Mr. Aditya Arun Kumar as a director, along with the appointments of the Secretarial and Cost Auditors. This meeting signifies important governance and financial updates for the company's stakeholders.